HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)

Market Cap	129.75B +3.1%
Revenue (ttm)	130.51B +9.2%
Net Income	252.62M -95.6%
EPS	8.42 -95.6%
Shares Out	30.00M
PE Ratio	11.25
Forward PE	n/a
Dividend	35.00 (0.78%)
Ex-Dividend Date	Apr 2, 2026

Volume	97,081
Average Volume	79,964
Open	4,460.00
Previous Close	4,460.00
Day's Range	4,435.00 - 4,590.00
52-Week Range	3,965.00 - 5,420.00
Beta	0.85
RSI	48.95
Earnings Date	Apr 30, 2026

About HYUNDAI BIOLAND

HYUNDAI BIOLAND Co.,Ltd., together with its subsidiaries, manufactures and sells cosmetic raw materials, health food raw materials, medical devices, and pharmaceutical raw materials worldwide. The company offers cosmetics, such as whitening, skin protection, moisturizing, anti-aging, sheet mask, and hair and body care products, as well as general/health functional food ingredients. It is also involved in the provision of medical biomaterials for dental, wound, orthopedic, and biomaterial applications; and manufacture and supplying of active pha...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 341
• Stock Exchange: KOSDAQ
• Ticker Symbol: 052260

Financial Performance

In 2025, HYUNDAI BIOLAND's revenue was 130.51 billion, an increase of 9.19% compared to the previous year's 119.52 billion. Earnings were 252.62 million, a decrease of -95.57%.